Cannabis businesses pay insurance premiums 2-5x higher than comparable industries because most insurers refuse to underwrite federally illegal activity

The vast majority of insurance carriers will not underwrite cannabis businesses because cannabis remains federally illegal, and insurers fear that covering an illegal enterprise could void their own reinsurance treaties or expose them to federal liability. The few carriers willing to write cannabis policies charge substantial premiums: a cultivation business with $1.5 million in annual revenue and $250,000 in crop coverage received a quote of $125,000 for crop insurance alone -- an 8.3% premium-to-coverage ratio that is roughly 5x what a comparable agricultural operation would pay. Dispensaries pay $6,500-$7,500 per year for basic commercial package policies, and many critical coverage types (D&O, cyber liability, employment practices liability) are simply unavailable. Why it matters: Without affordable comprehensive insurance, a single catastrophic event -- a fire, a lawsuit, a crop failure -- can permanently destroy a cannabis business that has no safety net, so operators face existential risk every day that comparable businesses in legal industries do not. Because general liability limits are typically capped at $1M per occurrence/$2M aggregate, a serious customer injury lawsuit can exceed coverage and bankrupt the business, so operators are effectively self-insured for large claims. The lack of crop insurance means cultivators absorb 100% of losses from mold, pests, theft, or natural disasters, so a single bad harvest can wipe out a year's revenue with no recovery mechanism. Many cannabis businesses must pay their insurance premiums in cash because their insurer's payment processor will not handle cannabis funds, adding yet another logistical burden. The insurance gap makes cannabis businesses uninvestable by institutional capital that requires portfolio companies to carry standard coverage minimums, limiting the industry to high-risk private capital. The structural root cause is that the surplus lines and admitted insurance markets both depend on reinsurance from large global carriers (Swiss Re, Munich Re, Lloyd's) who will not touch cannabis risk while it remains federally scheduled. Without reinsurance backing, primary carriers cannot write large policies, so capacity in the cannabis insurance market remains artificially constrained.